SPEAKER: Dr. Christoph Alexiou

Head Division

Experimental Oncology and Nanomedicine

ENT-Clinic, Else Kröner-Fresenius-Stiftung-Professorship, Universitätsklinikum Erlangen,

Waldstr. 1, 91054 Erlangen, Germany

BIOSKETCH

Prof. Dr. Christoph Alexiou, born 2^nd of March 1967, received his Ph.D. in 1995 from the Technical University of Munich, Medical  school. After finishing his internship in the Gastroenterology Department at the Universityhospital of the Technical University he started as a physician and researcher at the Department of oto-rhino-laryngology, head and neck surgery and founded a research group working on the field of local chemotherapy with magnetic nanoparticles (Magnetic Drug Targeting). In the year 2000 he received his degree as an ENT-Physician and 2002 he changed to the ENT-Department in Erlangen, Germany, where he performed his postdoctoral lecture qualification (Habilitation). He is working there as an assistant medical director in the clinic and leads the Section for Experimental Oncology and Nanomedicine (SEON). Since 2009 he owns the Else Kröner-Fresenius-Stiftung-Professorship for Nanomedicine at the Universityhospital Erlangen. The aim of his resarch focus on the translation of Magnetic Drug Targeting into human trials and he received for his research several national and international awards.